22nd Anglonordic Life Science Conference

Event timezone:

My timezone:

REGISTRATION AND SPONSOR APPLICATIONS NOW OPEN!

Prices maintained - hurry!

Apply to Pitch

Startup companies are invited to present 10 minute pitches to investors and potential collaborators

Sponsor or Exhibit

Sponsor the conference, or purchase exhibit space to promote your company and gain access to 1:1 partnering

Prices maintained until 1st Sept 2025!

Purchase your ticket or enter a sponsorship agreement before September 2025 to take advantage these lower prices.

WHY ATTEND?

Over 350 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, are expected to get together in London next April for the 22nd Annual Anglonordic Life Science Conference.

The Reception, our must-attend networking event, will take place, as always, the evening before the conference at a prestigious London venue.

At the last Anglonordic Life Science Conference 86 high quality investor firms attended. The conference Programme featured on-point panel discussions around European investment and technologies, and 36 funding pitches were presented by cutting-edge biomedical and healthcare startups. 1:1 partnering took place throughout the day, with every meeting slot filled.

View the 2025 Programme

With the support of M Ventures as lead and founding sponsor, and rich, engaging content devised and coordinated by Optimum Strategic Communications, Anglonordic is one of the top networking and partnering events in the life sciences calendar, and the unique R&D-to-investor conference in the UK.

2025 prices maintained until Sept 2025 - register now!

We are currently preparing the programme for the 2026 event. In the meantime, the 2025 programme is still available to view:

View 2025 Programme

Charity of the Year

The 2025 Charity of the Year was Cure Parkinson's

We invite applications for the 2026 COTY:

Find out more

350+ Attendees

Exclusively selected attendees represent the following key drivers of the European life sciences growth sector:

CEOs, CSOs and Heads of Business Development from Emerging Life Science Companies in the Anglo-Nordic regions and Continental Europe
Decision-makers from Europe's key Investor firms and Pharma companies
Key Supporters of the Life Science Ecosystem in Europe
Country delegations: hand-picked growth companies from global life science clusters

80+ Investor Firms

Anglonordic celebrates a 22-year tradition of attracting leading life science investment firms with funds.

We are expecting over 80 investment firms to attend. Based across Europe, these funders have interests in a wide variety of technologies from small molecule discovery through protein technologies to AI applications and healthcare devices.

View the list of investors who attended the 2025 event.

36 Startup Pitches

High quality, investor-selected growth companies

Company pitches are selected by our investor panel from a broad set of applicants
We encourage biotech, medtech and technology startups to apply
Developing ground-breaking technologies, these companies will be seeking funding and/or collaborations

300+ Partnering Meetings

Networking and 1:1 meetings

Networking is high on the priority list for Anglonordic delegates. Business discussions start well ahead of the conference, via our networking and 1:1 meeting scheduling platform. The platform features rich company/investor profiling plus instant messaging. Over 1,000 meeting requests and 5,000 messages were sent last year.